Research project

Therapeutic MOA and efficacy of anti-TIGIT antagonist: Comparison of isotypes and role of Fc receptor

Staff

Lead researchers

Professor Mark Cragg

Professor in Experimental Cancer Biology
Research interests
  • Antibody biology
  • Antibody engineering
  • Cancer Immunotherapy
Connect with Mark

Other researchers

Professor Sean Lim

Professor of Haematology
Research interests
  • Identification of new therapeutic targets in lymphoma
  • Development of novel monoclonal antibody combination therapies for cancer
  • Understanding the determinants of an effective immune response in patients with lymphoma
Connect with Sean

Research outputs